Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance

Zhuan Zhou1, Xinxin Song1, Junlong Jack Chi2

  • 1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States.

Cellular Signalling
|February 22, 2020
PubMed

Insights

Krüppel-like factor 4 (KLF4) drives endocrine resistance in breast cancer by coordinating estrogen receptor signaling. Targeting the Src-VHL-KLF4 pathway can re-sensitize resistant tumors to tamoxifen.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Krüppel-like factor 4 (KLF4) is crucial for cellular events and implicated in cancers like breast cancer.
  • Posttranslational modifications regulate KLF4 activity, impacting its role in disease.
  • KLF4 deregulation is linked to poor prognosis and treatment resistance.

Purpose of the Study:

  • To investigate the role of KLF4 in estrogen receptor signaling and endocrine resistance in breast cancer.
  • To elucidate the molecular mechanisms by which KLF4 influences response to endocrine therapy.
  • To identify potential therapeutic targets for overcoming tamoxifen resistance.

Main Methods:

  • Immunohistochemistry (IHC) analysis of human breast cancer specimens.
  • Drug screening to identify modulators of KLF4 protein expression.
  • Biochemical assays to study protein interactions and modifications (phosphorylation, ubiquitylation).

Main Results:

  • KLF4 protein accumulates in ER-positive breast cancer tissues and correlates with poor prognosis and endocrine resistance.
  • Src kinase activity and VHL (von Hippel-Lindau tumor suppressor) ubiquitylation regulate KLF4 levels and tamoxifen resistance.
  • Phosphorylation of VHL by Src enhances KLF4-mediated endocrine resistance.
  • Targeting the Src-VHL-KLF4 axis with inhibitors or peptides re-sensitizes resistant cells.

Conclusions:

  • KLF4 plays a novel role in mediating endocrine resistance in breast cancer.
  • The Src-VHL-KLF4 signaling axis is a critical regulator of tamoxifen resistance.
  • Interventions targeting this pathway hold promise for treating endocrine-resistant breast cancer.

Related Concept Videos

Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
5.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.3K